357 related articles for article (PubMed ID: 25929571)
1. Nanoscaled boron-containing delivery systems and therapeutic agents for cancer treatment.
Wang J; Wu W; Jiang X
Nanomedicine (Lond); 2015; 10(7):1149-63. PubMed ID: 25929571
[TBL] [Abstract][Full Text] [Related]
2. Applications and perspectives of boron-enriched nanocomposites in cancer therapy.
Yinghuai Z; Hosmane NS
Future Med Chem; 2013 Apr; 5(6):705-14. PubMed ID: 23617432
[TBL] [Abstract][Full Text] [Related]
3. Polyhedral boron compounds as potential diagnostic and therapeutic antitumor agents.
Bregadze VI; Sivaev IB; Glazun SA
Anticancer Agents Med Chem; 2006 Mar; 6(2):75-109. PubMed ID: 16529534
[TBL] [Abstract][Full Text] [Related]
4. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
[TBL] [Abstract][Full Text] [Related]
5. Dendrimers and dendritic polymers in drug delivery.
Gillies ER; Fréchet JM
Drug Discov Today; 2005 Jan; 10(1):35-43. PubMed ID: 15676297
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas.
Dai C; Cai F; Hwang KC; Zhou Y; Zhang Z; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wei J; Jiao Y; Wei Z; Ma W; Wang R
Sci China Life Sci; 2013 Feb; 56(2):163-73. PubMed ID: 23334699
[TBL] [Abstract][Full Text] [Related]
8. The formulation of polyhedral boranes for the boron neutron capture therapy of cancer.
Calabrese G; Nesnas JJ; Barbu E; Fatouros D; Tsibouklis J
Drug Discov Today; 2012 Feb; 17(3-4):153-9. PubMed ID: 21978988
[TBL] [Abstract][Full Text] [Related]
9. [Boron delivery system for neutron capture therapy of cancer].
Nakamura H
Rinsho Ketsueki; 2008 May; 49(5):294-301. PubMed ID: 18572805
[No Abstract] [Full Text] [Related]
10. Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application.
Achilli C; Grandi S; Ciana A; Guidetti GF; Malara A; Abbonante V; Cansolino L; Tomasi C; Balduini A; Fagnoni M; Merli D; Mustarelli P; Canobbio I; Balduini C; Minetti G
Nanomedicine; 2014 Apr; 10(3):589-97. PubMed ID: 24161383
[TBL] [Abstract][Full Text] [Related]
11. Rational design of gold nanoparticles functionalized with carboranes for application in Boron Neutron Capture Therapy.
Ciani L; Bortolussi S; Postuma I; Cansolino L; Ferrari C; Panza L; Altieri S; Ristori S
Int J Pharm; 2013 Dec; 458(2):340-6. PubMed ID: 24140178
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery system design and development for boron neutron capture therapy on cancer treatment.
Sherlock Huang LC; Hsieh WY; Chen JY; Huang SC; Chen JK; Hsu MH
Appl Radiat Isot; 2014 Jun; 88():89-93. PubMed ID: 24447933
[TBL] [Abstract][Full Text] [Related]
13. Application of cycloaddition reactions to the syntheses of novel boron compounds.
Zhu Y; Siwei X; Maguire JA; Hosmane NS
Molecules; 2010 Dec; 15(12):9437-49. PubMed ID: 21178899
[TBL] [Abstract][Full Text] [Related]
14. Dendrimers in oncology: an expanding horizon.
Tekade RK; Kumar PV; Jain NK
Chem Rev; 2009 Jan; 109(1):49-87. PubMed ID: 19099452
[No Abstract] [Full Text] [Related]
15. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
[TBL] [Abstract][Full Text] [Related]
16. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
[TBL] [Abstract][Full Text] [Related]
17. Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.
Tachikawa S; Miyoshi T; Koganei H; El-Zaria ME; Viñas C; Suzuki M; Ono K; Nakamura H
Chem Commun (Camb); 2014 Oct; 50(82):12325-8. PubMed ID: 25182569
[TBL] [Abstract][Full Text] [Related]
18. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
[TBL] [Abstract][Full Text] [Related]
19. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
20. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
